Normal view MARC view ISBD view

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.

Miglietta, Daniela

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy. [electronic resource] - Orphanet journal of rare diseases Aug 2015 - 101 p. digital

Publication Type: Journal Article

ISSN: 1750-1172

Standard No.: 10.1186/s13023-015-0311-0 doi

Subjects--Topical Terms:
Animals
Biological Availability
Disease Models, Animal
Male
Mice
Mice, Inbred C57BL
Mice, Inbred mdx
Muscular Dystrophy, Duchenne--drug therapy
Naproxen--analogs & derivatives
Nitric Oxide Donors--pharmacokinetics

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)